HomeIOVA • NASDAQ
add
Iovance Biotherapeutics Inc
Nakaraang pagsara
$3.79
Sakop ng araw
$3.57 - $3.75
Sakop ng taon
$1.64 - $4.35
Market cap
1.47B USD
Average na Volume
14.83M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 86.77M | 17.74% |
Gastos sa pagpapatakbo | 117.12M | -4.38% |
Net na kita | -71.90M | 8.47% |
Net profit margin | -82.87 | 22.26% |
Kita sa bawat share | -0.18 | 30.77% |
EBITDA | -63.53M | 12.46% |
Aktuwal na % ng binabayarang buwis | -0.26% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 296.98M | -8.28% |
Kabuuang asset | 913.17M | 0.30% |
Kabuuang sagutin | 214.59M | 7.28% |
Kabuuang equity | 698.58M | — |
Natitirang share | 411.96M | — |
Presyo para makapag-book | 2.23 | — |
Return on assets | -20.20% | — |
Return on capital | -24.44% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -71.90M | 8.47% |
Cash mula sa mga operasyon | -52.56M | 28.28% |
Cash mula sa pag-invest | 775.00K | -96.73% |
Cash mula sa financing | 56.17M | 2,332.74% |
Net change in cash | 4.96M | 110.23% |
Malayang cash flow | -33.38M | 15.15% |
Tungkol
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
Itinatag
2007
Headquarters
Website
Mga Empleyado
975
